HLB Therapeutics Co.,Ltd.s 38 percent Share Price Surge Not Quite Adding Up - Simply Wall St
| 047920 Stock | KRW 30,750 800.00 2.54% |
About 62% of HLB Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in HLB Pharmaceutical Co suggests that many traders are alarmed regarding HLB Pharmaceutical's prospects. The current market sentiment, together with HLB Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use HLB Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
HLB |
HLB Therapeutics Co.,Ltd.s 38 percent Share Price Surge Not Quite Adding Up Simply Wall St
Read at news.google.com
 |
HLB Pharmaceutical Fundamental Analysis
We analyze HLB Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HLB Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HLB Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
HLB Pharmaceutical is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
HLB Pharmaceutical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with HLB Pharmaceutical stock to make a market-neutral strategy. Peer analysis of HLB Pharmaceutical could also be used in its relative valuation, which is a method of valuing HLB Pharmaceutical by comparing valuation metrics with similar companies.
Peers
HLB Pharmaceutical Related Equities
| 037460 | Samji Electronics | 12.15 | ||||
| 017670 | SK Telecom | 0.53 | ||||
| 014910 | SungMoon Electronics | 0.60 | ||||
| 008060 | Daeduck Electronics | 0.84 | ||||
| 35320K | DAEDUCK ELECTRONICS | 0.86 | ||||
| 005680 | Samyoung Electronics | 2.06 | ||||
| 036010 | ABCO Electronics | 3.12 |
Complementary Tools for HLB Stock analysis
When running HLB Pharmaceutical's price analysis, check to measure HLB Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HLB Pharmaceutical is operating at the current time. Most of HLB Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of HLB Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HLB Pharmaceutical's price. Additionally, you may evaluate how the addition of HLB Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |